Oral HIF-2α Inhibitor Belzutifan in Ocular von Hippel-Lindau Disease: Subgroup Analysis of the Single-Arm Phase 2 LITESPARK-004 Study.
Wiley HE, Srinivasan R, Maranchie JK, Chhablani J, Bøndergaard Iversen AB, Kruse A, Jonasch E, Gombos DS, Else T, Demirci H, Maughan BL, Hartnett ME, Coleman HR, Fu W, Perini RF, Liu Y, Linehan WM, Chew EY; LITESPARK-004 Investigator Group – Ocular VHL.
Wiley HE, et al. Among authors: chew ey.
Ophthalmology. 2024 Jun 5:S0161-6420(24)00319-1. doi: 10.1016/j.ophtha.2024.05.024. Online ahead of print.
Ophthalmology. 2024.
PMID: 38849055